SCHEMBL6849577

SCHEMBL6849577

O=C(O)c1coc2cnccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.48
KDM4C Q9H3R0 13/20 0.46
KDM6B O15054 5/20 0.46
KDM4D Q6B0I6 4/20 0.46
KDM4E B2RXH2 3/20 0.46
KDM4A O75164 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAOB P27338 1/20 0.45
KDM5C P41229 1/20 0.38
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
CSNK2A3 Q8NEV1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3610557 0.73 MTNR1A (0.45) MTNR1AKDM4CKDM4EALDH1A1MAOB
SCHEMBL70456 0.73 MAOB (0.76) KDM4CALDH1A1MAPTMAOB
SCHEMBL15231477 0.73 XDH (0.36) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL27822584 0.72 MAOB (0.73) KDM4CALDH1A1MAPTMAOB
Hydrochloric Acid SCHEMBL87683 0.72 MAOB (0.73) KDM4CALDH1A1MAPTMAOB
SCHEMBL11656262 0.71 KDM4C (0.53) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL16931334 0.70 SIRT3 (0.47) MTNR1AKDM4CKDM6BKDM4DKDM4E
SCHEMBL246967 0.69 MTNR1A (0.42) MTNR1AKDM4EALDH1A1MAOBPIM1
SCHEMBL8341650 0.69 MTNR1A (0.45) MTNR1AKDM4EALDH1A1TDP1
SCHEMBL204082 0.69 PIM1 (0.54) KDM4EALDH1A1MAPTTDP1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432707-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-06-30 EP claimed
WO-2003029252-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-04-10 WO claimed
EP-1432707-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-06-30 EP disclosed
WO-2003029252-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-04-10 WO disclosed